Moderna MRNA
NASDAQ MRNA
$218.00 -18.50 (-7.82%)
As of: Oct 16, 2026 · 3:59 PM EDT

Moderna (MRNA) Return on Invested Capital [ROIC] (2026)

Updated

Moderna's Return on Invested Capital [ROIC] was -43.26% in Q2 2026, down 3.67 percentage points from the prior quarter.

Analysis

Moderna (MRNA) Return on Invested Capital [ROIC] (2026) Analysis & Trends

For FY2025, Return on Invested Capital [ROIC] at Moderna came in at -30.52%.

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) ROIC (Qtr)
1 Eli Lilly 1,122.91 Bn 1,091.50 Bn 19.71 Bn 37.16%
2 Johnson & Johnson 615.09 Bn 533.62 Bn 17.26 Bn 16.10%
3 AbbVie 504.75 Bn 477.86 Bn 12.70 Bn 18.68%
4 Merck 360.18 Bn 314.55 Bn 12.21 Bn 3.56%
5 Novartis Ag 292.05 Bn 256.04 Bn 11.24 Bn 34.87%
6 Astrazeneca 256.09 Bn 229.78 Bn 12.86 Bn 23.26%
7 Amgen 233.63 Bn 189.02 Bn 7.24 Bn 14.33%
8 Gilead Sciences 194.49 Bn 168.69 Bn 6.22 Bn -5.97%
9 Pfizer 168.35 Bn 114.99 Bn 10.94 Bn 13.44%
10 Moderna 85.93 Bn 65.29 Bn 52.00 Mn -43.26%
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 -43.26%
Mar 31, 2026 -39.59%
API Access

Moderna Return on Invested Capital [ROIC] API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=return-on-invested-capital-%5Broic%5D&ticker=MRNA&period=max&api_key=YOUR_API_KEY